imipramine has been researched along with Parodontosis in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamawaki, Y | 1 |
| So, H | 1 |
| Oue, K | 1 |
| Asano, S | 1 |
| Furusho, H | 1 |
| Miyauchi, M | 1 |
| Tanimoto, K | 1 |
| Kanematsu, T | 1 |
1 other study available for imipramine and Parodontosis
| Article | Year |
|---|---|
Imipramine prevents Porphyromonas gingivalis lipopolysaccharide-induced microglial neurotoxicity.
Topics: Animals; Imipramine; Inflammation; Lipopolysaccharides; Mice; Microglia; NF-kappa B; Periodontal Dis | 2022 |